Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma

BACKGROUND: Anti-programmed death (PD)-1 therapy has recently been used in recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC). The long-term survival and its biomarkers responding to anti-PD-1 treatment in patients with R/M NPC remain unclear. METHODS: Patients with R/M NPC were enrolled b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yuxiang, Chen, Xi, Wang, Ao, Zhao, Hongyun, Lin, Qingguang, Bao, Hua, Zhang, Yang, Hong, Shaodong, Tang, Wanxiangfu, Huang, Yan, Yang, Yunpeng, Wu, Xue, Shao, Yang, Fang, Wenfeng, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978327/
https://www.ncbi.nlm.nih.gov/pubmed/33737344
http://dx.doi.org/10.1136/jitc-2020-002014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978327/
https://www.ncbi.nlm.nih.gov/pubmed/33737344
http://dx.doi.org/10.1136/jitc-2020-002014

Ejemplares similares